ALKT
BEARISH
$18.0
Live
Alkami Technology, Inc. · NASDAQ
Target $22.67
(+25.9%)
$14.11
52W Range
$31.66
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Mar 14, 2026
Market cap
$1.91B
P/E
N/A
ROE
-13.3%
Profit margin
-10.7%
Debt/Equity
1.02
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
ALKT's deterministic health scores signal significant financial distress: the Piotroski F-Score of 2/9 indicates weak operational and financial health, while the absence of an Altman Z-Score raises concerns about bankruptcy risk. Despite strong revenue growth of 34.7% YoY and a gross margin of 57.84%, the company remains unprofitable with negative ROE (-13.25%), ROA (-4.72%), and a profit margin of -10.74%. Insider selling totaling $1.54M over six months, coupled with a bearish technical trend and a 52-week price decline of 28.8%, underscores deteriorating sentiment. The stock trades at a premium valuation (P/B 5.28, Forward P/E 16.31) despite negative earnings, suggesting overvaluation relative to fundamentals.
Key Strengths
Strong revenue growth at 34.7% YoY
High gross margin of 57.84% indicates pricing power and cost efficiency
Healthy current ratio (2.09) and quick ratio (1.68) suggest short-term liquidity
Positive earnings surprises in earlier quarters (e.g., +87.1% in Q1 2024)
Analyst consensus recommends 'buy' with a target price of $22.67 (20.4% upside)
Key Risks
Piotroski F-Score of 2/9 indicates severe financial and operational weakness
Negative profitability across all key metrics (ROE, ROA, profit margin)
Significant insider selling (7 transactions, $1.54M) with no buys in 6 months
Debt/Equity ratio of 1.02 is elevated, especially for a loss-making firm
Stock has underperformed over 1-year (-28.7%) and 6-month (-28.8%) periods
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
33
Weak
35
65
40
25
0
AI Verdict
Weak
Key drivers: Low Piotroski F-Score (2/9), Negative profitability and cash flow, High insider selling, Overvaluation relative to earnings, Declining price trend
Confidence
88%
Value
35/100
Ref P/E, PEG, Graham Number
Positives
- Forward P/E of 16.31 is below sector average (77.60)
- Price/Sales of 4.31 is moderate for a growth software firm
Watchpoints
- No Graham Number or intrinsic value due to negative earnings
- Stock trades at a premium to book value (P/B 5.28)
- High valuation unsupported by profitability
Future
65/100
Ref Growth rates
Positives
- 34.7% YoY revenue growth is strong
- Recent quarters show recovery in earnings from deep losses
- Analyst target implies 20% upside
Watchpoints
- Earnings growth is negative (-18.2% YoY)
- Most recent Q/Q EPS growth is -30.8%
- Forward P/E is based on projected earnings, not current profitability
Past
40/100
Ref Historical trends
Positives
- Historical earnings surprises were occasionally positive (e.g., +87.1% in Q1 2024)
- Consistent revenue growth over multiple quarters
Watchpoints
- Persistent losses over 21 quarters
- Negative EPS in 17 of 21 quarters
- One quarter showed a -964.9% surprise (Q1 2021)
Health
25/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Current ratio of 2.09 and quick ratio of 1.68 indicate liquidity strength
- No Altman Z-Score available, but debt/equity of 1.02 is high for a loss-making firm
Watchpoints
- Piotroski F-Score of 2/9 is critically low
- Negative ROE, ROA, and ROIC
- No positive cash flow or free cash flow data
- No Altman Z-Score implies potential distress risk
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout
- Payout ratio is 0.00%
- Company is not dividend-paying
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$18.0
Analyst Target
$22.67
Upside/Downside
+25.9%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ALKT and closest competitors.
Updated 2026-03-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ALKT
Alkami Technology, Inc.
Primary
|
-58.1% | +42.7% | -28.7% | -28.8% | +6.8% | +5.5% |
|
FORTY
Formula Systems (1985) Ltd.
Peer
|
+46.6% | +103.2% | +45.4% | -16.8% | -2.9% | -0.3% |
|
AGYS
Agilysys, Inc.
Peer
|
+17.1% | -15.7% | -4.1% | -35.3% | -20.0% | -11.6% |
|
APPN
Appian Corporation
Peer
|
-85.0% | -37.5% | -11.8% | -16.9% | +9.3% | -3.9% |
|
MXL
MaxLinear, Inc.
Peer
|
-42.6% | -31.6% | +117.8% | +27.7% | +24.5% | +17.1% |
ALK
Alkami Technology, Inc.
Primary
5Y
-58.1%
3Y
+42.7%
1Y
-28.7%
6M
-28.8%
1M
+6.8%
1W
+5.5%
FOR
Formula Systems (1985) Ltd.
Peer
5Y
+46.6%
3Y
+103.2%
1Y
+45.4%
6M
-16.8%
1M
-2.9%
1W
-0.3%
AGY
Agilysys, Inc.
Peer
5Y
+17.1%
3Y
-15.7%
1Y
-4.1%
6M
-35.3%
1M
-20.0%
1W
-11.6%
APP
Appian Corporation
Peer
5Y
-85.0%
3Y
-37.5%
1Y
-11.8%
6M
-16.9%
1M
+9.3%
1W
-3.9%
MXL
MaxLinear, Inc.
Peer
5Y
-42.6%
3Y
-31.6%
1Y
+117.8%
6M
+27.7%
1M
+24.5%
1W
+17.1%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
16.31
PEG Ratio
N/A
P/B Ratio
5.28
P/S Ratio
4.31
EV/Revenue
4.91
EV/EBITDA
-57.06
Market Cap
$1.91B
Profitability
Profit margins and return metrics
Profit Margin
-10.74%
Operating Margin
-7.59%
Gross Margin
57.84%
ROE
-13.25%
ROA
-4.72%
Growth
Revenue and earnings growth rates
Revenue Growth
+34.7%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
1.02
Moderate
Current Ratio
2.09
Strong
Quick Ratio
1.68
Excellent
Cash/Share
$0.93
Quarterly Earnings History
EPS performance vs analyst estimates
2026-04-29
$N/A
2026-02-25
$0.09
-37.5% surprise
2025-10-30
$0.13
+8.2% surprise
2025-07-30
$0.07
-9.9% surprise
Technology Sector Comparison
Comparing ALKT against 565 companies in the Technology sector
(45 bullish, 197 neutral, 323 bearish)
Return on Equity (ROE)
-13.25%
This Stock
vs
-33.47%
Sector Avg
-60.4%
(Below Avg)
Profit Margin
-10.74%
This Stock
vs
-11.75%
Sector Avg
-8.6%
(Weaker)
Debt to Equity
1.02
This Stock
vs
0.74
Sector Avg
+36.9%
(Higher)
Revenue Growth
34.7%
This Stock
vs
4383.21%
Sector Avg
-99.2%
(Slower)
Current Ratio
2.09
This Stock
vs
3.59
Sector Avg
-41.7%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ALKT
Alkami Technology, Inc.
|
BEARISH | $1.91B | - | -13.3% | -10.7% | $18.0 | |
|
FORTY
Formula Systems (1985) Ltd.
|
BEARISH | $1.91B | 54.11 | 6.9% | 23.1% | $124.45 | Compare |
|
AGYS
Agilysys, Inc.
|
BEARISH | $1.93B | 64.01 | 10.7% | 9.8% | $68.49 | Compare |
|
APPN
Appian Corporation
|
NEUTRAL | $1.89B | 1279.5 | -% | 0.2% | $25.59 | Compare |
|
MXL
MaxLinear, Inc.
|
NEUTRAL | $1.93B | - | -28.2% | -29.2% | $21.56 | Compare |
ALKT
Alkami Technology, Inc.
BEARISH
Mkt Cap
$1.9B
P/E
-
ROE
-13.3%
Price
$18.0
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-11 | GENERAL ATLANTIC L.P. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | 2,846,015 | $50,564,148 |
| 2026-03-09 | SHOOTMAN ALEX P | Chief Executive Officer | Sale | 10,876 | $180,433 |
| 2026-03-04 | LINEBARGER DOUGLAS A | Officer | Stock Award | 133,011 | - |
| 2026-03-04 | SACHDEVA PRERNA | Officer | Stock Award | 24,184 | - |
| 2026-03-04 | SHOOTMAN ALEX P | Chief Executive Officer | Stock Award | 423,217 | - |
| 2026-03-02 | HUDSON CASSANDRA | Chief Financial Officer | Sale | 6,869 | $116,086 |
| 2026-03-02 | LINEBARGER DOUGLAS A | Officer | Sale | 5,518 | $93,254 |
| 2026-03-02 | SACHDEVA PRERNA | Officer | Sale | 1,352 | $22,849 |
| 2026-01-05 | ALVAREZ MARIA INES | Director | Stock Award | 255 | - |
| 2026-01-05 | MITCHELL STEVEN RYAN | Director | Stock Award | 396 | - |
| 2026-01-05 | SMITH BRIAN R | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award | 877 | - |
| 2025-12-09 | SHOOTMAN ALEX P | Chief Executive Officer | Sale | 42,930 | $941,026 |
| 2025-12-02 | LINEBARGER DOUGLAS A | Officer | Sale | 8,179 | $166,361 |
| 2025-12-02 | SACHDEVA PRERNA | Officer | Sale | 1,101 | $22,394 |
| 2025-11-28 | HUDSON CASSANDRA | Chief Financial Officer | Stock Award | 293,626 | - |
GENERAL ATLANTIC L.P.
Director and Beneficial Owner of more than 10% of a Class of Security
2026-03-11
2,846,015 shares
·
$50,564,148
SHOOTMAN ALEX P
Chief Executive Officer
2026-03-09
10,876 shares
·
$180,433
LINEBARGER DOUGLAS A
Officer
2026-03-04
133,011 shares
SACHDEVA PRERNA
Officer
2026-03-04
24,184 shares
SHOOTMAN ALEX P
Chief Executive Officer
2026-03-04
423,217 shares
HUDSON CASSANDRA
Chief Financial Officer
2026-03-02
6,869 shares
·
$116,086
LINEBARGER DOUGLAS A
Officer
2026-03-02
5,518 shares
·
$93,254
SACHDEVA PRERNA
Officer
2026-03-02
1,352 shares
·
$22,849
ALVAREZ MARIA INES
Director
2026-01-05
255 shares
MITCHELL STEVEN RYAN
Director
2026-01-05
396 shares
SMITH BRIAN R
Director and Beneficial Owner of more than 10% of a Class of Security
2026-01-05
877 shares
SHOOTMAN ALEX P
Chief Executive Officer
2025-12-09
42,930 shares
·
$941,026
LINEBARGER DOUGLAS A
Officer
2025-12-02
8,179 shares
·
$166,361
SACHDEVA PRERNA
Officer
2025-12-02
1,101 shares
·
$22,394
HUDSON CASSANDRA
Chief Financial Officer
2025-11-28
293,626 shares
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
9 analysts
Barclays
2026-02-26
Equal-Weight
Equal-Weight
Citizens
2026-02-26
Market Outperform
Market Outperform
Needham
2026-02-26
Buy
Buy
JP Morgan
2026-02-18
Overweight
Overweight
Citizens
2026-01-29
Market Outperform
Market Outperform
Goldman Sachs
2025-11-03
Neutral
Neutral
JP Morgan
2025-10-31
Overweight
Overweight
Barclays
2025-10-31
Equal-Weight
Equal-Weight
Citizens
2025-10-31
Market Outperform
Market Outperform
Needham
2025-10-31
Buy
Buy
Past News Coverage
Recent headlines mentioning ALKT from our newsroom.
Newest → oldest
No matching news yet.